企业认证
成都伊诺达博医药科技有限公司
We are offering three key services for new drug application,
a. Mature(repeatable) pilot process with independent intellectual property rights;
b. High purity sample designed for pharm companies;
c. Impurity study.
Our main products are Ulipristal acetate intermediates &impurities; Alogliptin benzoate intermediates, impurities &metabolin; Ezetimibe intermediates &impurities; Abiraterone Acetate; Dienogest; Tenofovir disoproxil fumarate & its intermediates; Bortezomib; Cabazitaxel; Lacosamide intermediates; Minodronic acid.
| 公司成立时间 |
2007/12/4 0:00:00 |
注册资本 |
1500万元人民币 |
| 经营范围 |
研发、生产、销售：医药中间体，化学药品、生物药品的技术开发及转让，化工产品的销售，其它无需审批或许可的合法项目。
查看产品目录 |
| 公司地址 |
1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone, |
| 经营模式 |
工厂,工厂 |
主营行业 |
医药中间体,医药中间体,原料药,原料药 |
该企业工商信息校验数据由天眼查提供